Q1 2022 EPS Estimates for Masimo Co. (NASDAQ:MASI) Lowered by Analyst

Masimo Co. (NASDAQ:MASIGet Rating) – Investment analysts at Piper Sandler dropped their Q1 2022 EPS estimates for shares of Masimo in a report released on Tuesday, April 12th. Piper Sandler analyst J. Bednar now forecasts that the medical equipment provider will post earnings per share of $0.86 for the quarter, down from their previous estimate of $1.02. Piper Sandler has a “Neutral” rating and a $160.00 price objective on the stock. Piper Sandler also issued estimates for Masimo’s Q3 2022 earnings at $1.03 EPS, Q4 2022 earnings at $1.18 EPS, FY2022 earnings at $4.18 EPS, Q1 2023 earnings at $1.07 EPS, Q2 2023 earnings at $1.13 EPS, Q3 2023 earnings at $1.13 EPS, Q4 2023 earnings at $1.32 EPS and FY2023 earnings at $4.65 EPS.

A number of other equities analysts have also recently issued reports on the stock. TheStreet cut shares of Masimo from a “b-” rating to a “c+” rating in a research note on Tuesday, February 22nd. StockNews.com began coverage on shares of Masimo in a research note on Thursday, March 31st. They issued a “buy” rating on the stock. Wolfe Research began coverage on shares of Masimo in a research note on Tuesday, April 5th. They issued a “market perform” rating and a $160.00 price target on the stock. Stifel Nicolaus dropped their price target on shares of Masimo from $250.00 to $175.00 and set a “buy” rating on the stock in a research note on Thursday, March 31st. Finally, UBS Group lowered their target price on shares of Masimo from $325.00 to $295.00 and set a “buy” rating on the stock in a research note on Wednesday, February 16th. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Masimo currently has an average rating of “Buy” and an average target price of $229.00.

Shares of Masimo stock opened at $134.87 on Thursday. The stock has a market cap of $7.49 billion, a price-to-earnings ratio of 33.89 and a beta of 0.89. The firm’s 50-day moving average is $160.46 and its 200 day moving average is $232.66. Masimo has a 1 year low of $133.94 and a 1 year high of $305.21.

Masimo (NASDAQ:MASIGet Rating) last released its earnings results on Tuesday, February 15th. The medical equipment provider reported $1.21 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.10 by $0.11. The firm had revenue of $327.58 million for the quarter, compared to the consensus estimate of $320.75 million. Masimo had a net margin of 18.53% and a return on equity of 16.06%. The company’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.98 EPS.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Moneta Group Investment Advisors LLC increased its holdings in Masimo by 1.8% in the 3rd quarter. Moneta Group Investment Advisors LLC now owns 2,453 shares of the medical equipment provider’s stock worth $664,000 after acquiring an additional 44 shares in the last quarter. Knowledge Leaders Capital LLC increased its holdings in Masimo by 1.2% in the 3rd quarter. Knowledge Leaders Capital LLC now owns 3,780 shares of the medical equipment provider’s stock worth $1,023,000 after acquiring an additional 45 shares in the last quarter. Cambridge Investment Research Advisors Inc. increased its holdings in Masimo by 1.3% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 3,542 shares of the medical equipment provider’s stock worth $1,037,000 after acquiring an additional 47 shares in the last quarter. Northwestern Mutual Investment Management Company LLC increased its holdings in Masimo by 0.7% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 8,422 shares of the medical equipment provider’s stock worth $2,466,000 after acquiring an additional 55 shares in the last quarter. Finally, Archer Investment Corp increased its holdings in Masimo by 31.7% in the 3rd quarter. Archer Investment Corp now owns 241 shares of the medical equipment provider’s stock worth $65,000 after acquiring an additional 58 shares in the last quarter. 82.82% of the stock is owned by hedge funds and other institutional investors.

In other news, Director Adam Mikkelson sold 600 shares of the company’s stock in a transaction dated Tuesday, January 18th. The shares were sold at an average price of $228.70, for a total transaction of $137,220.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 9.10% of the stock is currently owned by corporate insiders.

Masimo Company Profile (Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Articles

Earnings History and Estimates for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.